0. L e i n i k k i , I s a b e l C. Shekarchi, Preston H. D o r s e t t , NIH, NINCDS, IDB, Bethesda, Md. Assay o f v i r u s -s p e c i f i c IgM a n t i b o d y l e v e l s i s u s e f u l i n t h e l a b o r a t o r y diaqnosis o f r e c e n t acquired o r c o n g e n i t a l i n f e c t i o n s from s i n g i e a c i t e o r e a r l y convalescent serum specimens. Unfort u n a t e l y , rheumatoid f a c t o r (RF) a c t i v i t y causes f a l s e p o s i t i v e r e s u l t s even when t h e l e v e l s o f RF a r e below t h e d e t e c t i o n o f a v a i l a b l e assay methods and c l i n i c a l f e a t u r e s do n o t suggest t h e presence o f RF. E l i m i n a t i o n o f t h i s f a l s e r e a c t i v i t y by sucrose d e n s i t y g r a d i e n t o r chromatographic s e p a r a t i o n o f IgM i s l a b o r ious and lowers t h e s e n s i t i v i t y o f t h e assay.
A new method employing a d s o r p t i o n o f sera w i t h imnoblized p r o t e i n -A f o l l o w e d by c l a s s -s p e c i f i c a n t i b o d y d e t e r m i n a t i o n u s i n g ELISA has s o l v e d t h i s problem. Small a l i q u o t s o f serum were cent r i f u g e d a f t e r m i x i n g w i t h p r o t e i n A sepharose. V i r u s -s p e c i f i c IgM and IgG a n t i b o d i e s were then assayed from t h e supernatant by ELISA u s i n g microcuvettes s e n s i t i z e d w i t h g r a d i e n t p u r i f i e d r ub e l l a o r measles v i r u s antigens and heavy-chain s p e c i f i c conjugates. By removing IgG, t h e a b s o r p t i o n e l i m i n a t e d f a l s e IgM posi t i v i t y due t o RF as shown by t e s t s w i t h both r u b e l l a and measle antisens. The a d s o r p t i o n d i d n o t s i g n i f i c a n t l y reduce t h e speci f i c -~~~ antibody t i t e r s .
The assay o f s p e c i f i c a n t i v i r a l IgM a n t i b o d i e s a f t e r adsorpt i o n w i t h p r o t e i n A by ELISA provides a s e n s i t i v e and s p e c i f i c method f o r t h e serodiagnosis o f r e c e n t o r c o n g e n i t a l v i r a l i nf e c t i o n s . The efficacy of cephalexin monohydrate 50 mg/kg/d was evaluated in a placebo-controlled, double-blind, crossover study of patients with cystic fibrosis. Over a 2 year period, 17 patients with mild-moderate disease were treated for 4 month intervals with either cephalexin or placebo. One patient developed drug-related vulvovaginitis and dropped-out of the study. Although colonization by cephalexin-resistant S. aureus was not observed, 2 patients had an increase in sputum concentration of Ps. aeru inosa during antibiotic therapy.
SEIZURES: NOT
Patie:ts previously colonized with 2 lo6 CFUIml Ps. aeruginosa of H. influenzae had no alteration in flora. Six of 8 patients colonized with 2 lo6 CFUlml S. aureus had a decrease in S. aureus concentration to < 104 CRJ/ml during treatment with cephalexin. During periods of drug treatment, significantly reduced S. aureus colonization (7% versus 26% of cultures), increased weight gain (1.2 versus 0.2 kg14 months) and less hospitalizations (2 versus 15) were observed (P < 0.01). There were no differences in pulmonary function tests, chest x-rays, or sputum production during periods of antibiotic or placebo treatment.
Cephalexin, when compared to placebo, altered the microbial flora and clinical course of some patients with cystic fibrosis.
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An increased i n c i d e n c e of i n g u i n a l h e r n i a s has been noted i n i n f a n t s w i t h c o n g e n i t a l cytomegalovirus (CMV) i n f e c t i o n s . However t h e s i g n i f i c a n c e o f t h i s a s s o c i a t i o n i s s t i l l p o o r l y defined. The incidence o f i n g u i n a l h e r n i a s was determined r e t r o s p e ct i v e l y i n 67 i n f a n t s and c h i l d r e n w i t h documented cytomegalov i r u s i n f e c t i o n s . A p r o s p e c t i v e study was a l s o conducted t o d e f i n e t h e i n c i d e n c e o f cytomegalovirus i n f e c t i o n i n 24 consecut i v e p a t i e n t s p r e s e n t i n g f o r s u r g i c a l r e p a i r o f an i n g u i n a l hernia.
The occurrence o f i n g u i n a l h e r n i a s i n p a t i e n t s w i t h congenit a l o r acquired cytomegalovirus i n f e c t i o n revealed an o v e r a l l incidence of 9.6% (7167) b u t an 18.4% (7138) incidence was noted among c o n g e n i t a l l y i n f e c t e d i n f a n t s .
NO. o f ~a t i e n t s No. o f o a t i e n t s Obs., Microbiol. 6 Path., Grace Maternity Hospital and Dalhousie University, Halifax, Nova Scotia, Canada. From Jan '69 to May '74, 10 of 11 LBW infants < 35 wk gestation died from GBS septicemia. A study was designed to test the hypothesis that mortality from GBS in these infants could be prevented. From Jun '74 to Dec '76, systemic P was started with in 2 hr of birth in all infants < 35 wk gestation (changed to < 2500 g from Jan '77) following throat, ear, rectal, umbilical and blood cultures. P was stopped within 48 hours if GBS was not isolated; otherwise P was continued for 10 days. From Jun '74 to Nov '77 when P was administered, no positive blood cultures and no deaths from GBS infection occurred in study infants The f~c t that 7 fullterm infants developed GBS septicemia during this period suggests that the virulence of the organism had not We s t u d i e d t h e s e c r e t o r y imnunologic response t o r e s p i r a t o r y s y n c y t i a l v i r u s (RSV) i n f e c t i o n i n 22 i n f a n t s h o s p i t a l i z e d f o r b r o n c h i o l i t i s o r pneumonia. Nasopharyngeal s e c r e t i o n s were obt a i n e d b s u c t i o n every o t h e r day d u r i n g h o s p i t a l i z a t i o n and ( i n most7 once i n convalescence. Shed e p i t h e l i a l c e l l s were s p o t t e d on s l i d e s and acetone-fixed. These were then examined by d o u b l e -l a b e l l i n g imnunofluorescence techniques f o r RSV and IgG, IgA o r IgM antibody. C e l l -f r e e s e c r e t i o n s were t i t r a t e d by i n d i r e c t fluorescence f o r anti-RSV IgG, IgA and IgM.
I n 19 o f 22 i n f a n t s IgA was seen c o a t i n g RSV-infected nasal e p i t h e l i a l c e l l s i n t h e f i r s t a v a i l a b l e s e c r e t i o n (day 1 t o 3 of h o s p i t a l i z a t i o n ) , and i n a l l 22 by t h e 4 t h day. C e l l -f r e e a n t i -RSV IgA was never e v i d e n t i n t h e f i r s t specimen and appeared, or t h e average, on t h e 6 t h h o s p i t a l day. I n c o n t r a s t , c e l l -a s s oc i a t e d IgG was seen i n o n l y 12 i n f a n t s , o f t e n as l a t e as t h e 4 t h day. C e l l -f r e e anti-RSV IgG appeared i n a l l i n f a n t s , on t h e average by t h e 4 t h day. RSV a n t i g e n was u n i v e r s a l l y present through t h e 5 t h h o s p i t a l day, and i n 112 o f i n f a n t s f o r 8 days.
Both IgA and IgG a n t i b o d y appear i n s e c r e t i o n s o f RSV i n f e c ted i n f a n t s much e a r l i e r than p r e v i o u s l y suspected, and t h e i r p o s s i b l e r o l e s b o t h i n cure and i n mucosal immune complex d i sease must be s e r i o u s l y considered.
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Assuming no change in GBS colonisation rate. these data sumort 
